RBM23, or RNA Binding Motif Protein 23, is a protein encoded by the RBM23 gene in humans. As its name suggests, this protein is a member of the RNA-binding protein family, which are proteins known to interact with RNA and play crucial roles in various aspects of RNA metabolism.Given its RNA-binding motif, it's likely involved in processing or regulating RNA in some capacity. This could include roles in transcription, pre-mRNA splicing, mRNA stability, mRNA transport, or translation.
RNA-binding proteins are essential for gene expression and cellular function, and dysregulation of these proteins can contribute to numerous diseases, including cancer and neurodegenerative disorders. Therefore, understanding the specific roles of RBM23 could provide important insights into these processes.The RBM23 protein is known to localize in the nucleus of cells, supporting its role in RNA processing or regulation. It's also predicted to be part of the spliceosome, a complex molecular machine that removes introns from pre-mRNA to produce mature mRNA. This suggests a potential role in splicing regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a DNA methyltransferase inhibitor, can influence gene expression, potentially affecting RBM23 activity indirectly. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, can modify chromatin structure and influence gene expression, possibly impacting RBM23. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Vorinostat, another histone deacetylase inhibitor, may affect gene expression and indirectly influence RBM23 activity. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium Butyrate, a short-chain fatty acid, acts as a histone deacetylase inhibitor, potentially affecting RBM23. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic Acid can influence gene expression and RNA processing, possibly impacting RBM23 activity. | ||||||
Spliceostatin A | 391611-36-2 | sc-507481 | 1 mg | $1800.00 | ||
Spliceostatin A, a splicing inhibitor, could indirectly affect RBM23 by altering splicing machinery dynamics. | ||||||
Uridine | 58-96-8 | sc-296685 sc-296685A | 1 g 25 g | $60.00 $98.00 | 1 | |
Uridine, a nucleoside, can influence RNA metabolism and might indirectly affect RBM23. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
Etoposide, a topoisomerase II inhibitor, could indirectly impact RBM23 by affecting RNA transcription and processing. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D inhibits RNA polymerase, potentially influencing RBM23 activity indirectly by affecting RNA synthesis. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Mithramycin A, a DNA-binding antibiotic, can influence gene expression, potentially affecting RBM23. | ||||||